Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Afatinib × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Esophageal Squamous Cell Carcinoma 3 NSCLC 2 Carcinoma, Squamous Cell 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 PFS 1 Neoplasms 1 NRG1-fused Non-small Cell Lung Cancer 1 Focus of Study Instead 1 EGFR Mutation Positive Non-small Cell Lung Cancer 1 Cancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation 1 Breast Neoplasms 1

Interventions

Gemcitabine 63 Fluorouracil 22 130-nm albumin-bound paclitaxel 19 Oxaliplatin 18 Leucovorin 13 Capecitabine 13 S 1 (combination) 12 Albumin-Bound Paclitaxel 12 Taxes 9 Radiosurgery 9 folfirinox 8 Irinotecan 8 Radiotherapy 6 Cisplatin 6 pembrolizumab 5 Pancreaticoduodenectomy 5 Drug Therapy 5 irinotecan sucrosofate 4 apatinib 4 Radiofrequency Ablation 4 Paclitaxel 4 Injections 4 Blood Specimen Collection 4 Biopsy 4 tislelizumab 3 rubitecan 3 Stents 3 Sorafenib 3 Radiation 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02975141 2018-08-13

AFFECT

Ludwig-Maximilians - University of Munich

Phase 1 Unknown

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡